Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Enterprise Value: 2018-2019

Historic Enterprise Value for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $32.7 million.

  • DiaMedica Therapeutics' Enterprise Value rose 45.06% to $32.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $32.7 million, marking a year-over-year increase of 428.40%. This contributed to the annual value of $256.7 million for FY2024, which is 138.16% up from last year.
  • Per DiaMedica Therapeutics' latest filing, its Enterprise Value stood at $32.7 million for Q4 2019, which was down 2.45% from $33.5 million recorded in Q3 2019.
  • DiaMedica Therapeutics' Enterprise Value's 5-year high stood at $33.5 million during Q3 2019, with a 5-year trough of -$6.7 million in Q1 2018.
  • Over the past 2 years, DiaMedica Therapeutics' median Enterprise Value value was $22.3 million (recorded in 2018), while the average stood at $15.6 million.
  • Data for DiaMedica Therapeutics' Enterprise Value shows a peak YoY spiked of 958.95% (in 2019) over the last 5 years.
  • Over the past 2 years, DiaMedica Therapeutics' Enterprise Value (Quarterly) stood at $22.5 million in 2018, then spiked by 45.06% to $32.7 million in 2019.
  • Its Enterprise Value stands at $32.7 million for Q4 2019, versus $33.5 million for Q3 2019 and $30.6 million for Q2 2019.